Pharmaceutical Firm and Solve.Care Partner to Develop Blockchain Network for Helping Diabetics

  • Pharmaceutical firm Boehringer Ingelheim to work with to develop distributed ledger technology (DLT)-enabled solution for diabetes patients.
  • In particular, Germany-headquartered pharmaceutical company, Boehringer Ingelheim has partnered with blockchain-focused healthcare platform, Solve.
  • Care for said service, which is tailored to meet the needs of diabetic patients and promoted data sharing.

Read full article: